Literatura científica selecionada sobre o tema "Gray platelet syndrome"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Gray platelet syndrome".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Gray platelet syndrome"
Wills, E. J. "Gray Platelet Syndrome". Ultrastructural Pathology 13, n.º 4 (janeiro de 1989): 451–55. http://dx.doi.org/10.3109/01913128909048495.
Texto completo da fonteMichelson, Alan D. "Gray platelet syndrome". Blood 121, n.º 2 (10 de janeiro de 2013): 250. http://dx.doi.org/10.1182/blood-2012-09-455550.
Texto completo da fonteBain, Barbara J., e Manju Bhavnani. "Gray platelet syndrome". American Journal of Hematology 86, n.º 12 (28 de julho de 2011): 1027. http://dx.doi.org/10.1002/ajh.22055.
Texto completo da fonteRosa, Jean-Philippe. "The gray platelet syndrome". Sang thrombose vaisseaux 26, n.º 5 (setembro de 2014): 240–54. http://dx.doi.org/10.1684/stv.2014.0854.
Texto completo da fonteRosa, Jean-Philippe. "The gray platelet syndrome". Hématologie 19, n.º 2 (março de 2013): 123–35. http://dx.doi.org/10.1684/hma.2013.0793.
Texto completo da fonteBaruch, Dominique, Theo Lindhout, Evelyne Dupuy e Jacques P. Caen. "Thrombin-Induced Platelet Factor Va Formation in Patients with a Gray Platelet Syndrome". Thrombosis and Haemostasis 58, n.º 02 (1987): 768–71. http://dx.doi.org/10.1055/s-0038-1645967.
Texto completo da fonteTubman, Venée N., Jason E. Levine, Dean R. Campagna, Rita Monahan-Earley, Ann M. Dvorak, Ellis J. Neufeld e Mark D. Fleming. "X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation". Blood 109, n.º 8 (5 de janeiro de 2007): 3297–99. http://dx.doi.org/10.1182/blood-2006-02-004101.
Texto completo da fonteKöhler, Michael. "Treatment of Gray Platelet Syndrome". Thrombosis and Haemostasis 60, n.º 01 (1988): 123. http://dx.doi.org/10.1055/s-0038-1647649.
Texto completo da fonteNurden, Paquita, Martine Jandrot-Perrus, Robert Combrié, Joelle Winckler, Veronique Arocas, Christelle Lecut, Jean-Max Pasquet, Thomas J. Kunicki e Alan T. Nurden. "Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome". Blood 104, n.º 1 (1 de julho de 2004): 107–14. http://dx.doi.org/10.1182/blood-2003-11-3842.
Texto completo da fonteRao, A. Koneti, e Deepak A. Rao. "Gray platelet syndrome: immunity goes awry". Blood 136, n.º 17 (22 de outubro de 2020): 1898–900. http://dx.doi.org/10.1182/blood.2020008196.
Texto completo da fonteTeses / dissertações sobre o assunto "Gray platelet syndrome"
Delage, Laure. "Des déficiences génétiques comme modèles naturels pour l'étude de la régulation des checkpoints immunitaires et la caractérisation des réponses auto-immunes". Electronic Thesis or Diss., Université Paris Cité, 2021. http://www.theses.fr/2021UNIP5190.
Texto completo da fonteRecessive NBEAL2 mutations have been reported in patients with Gray Platelet Syndrome (GPS). This syndrome is characterized by a macro-thrombocytopenia, with platelets lacking alpha-granules, leading to bleeding disorders, often associated with splenomegaly. Thus, NBEAL2 plays a crucial role in the trafficking of alpha-granules in platelets. Moreover, our lab has also described NBEAL2 deficiencies in patients presenting clinical features of the autoimmune lymphoproliferative syndrome, suggesting a role of NBEAL2 in immune homeostasis and tolerance. A broader international cohort of GPS patients has been described, revealing immune system abnormalities (autoimmune diseases, autoantibodies, lymphopenia). If the role of NBEAL2 in the traffic of granules is often investigated, the exact mechanism leading to the development of autoimmune manifestations in GPS patients remains unknown. NBEAL2 belongs to a protein family involved in vesicular trafficking, all of which possess a conserved BEACH domain. Within this BEACH-domain containing proteins family, one of the closest members to NBEAL2 is LRBA. LRBA is involved in the recycling of CTLA-4, an inhibitory immune checkpoint. CTLA-4 plays a crucial role in the regulation of immune responses and tolerance. Recessive mutations of LRBA lead to similar clinical features as partial CTLA-4 deficiency: autoimmunity, lymphocytic infiltrations, and progressive B lymphopenia. Physiologically, LRBA prevents the lysosomal degradation of CTLA-4 and allows its recycling to the membrane. By analogy with LRBA, we investigated the importance of NBEAL2 in immune checkpoints intracellular trafficking and we brought new insights on its role in lymphocytes. Thus, NBEAL2 is a scaffold protein, binding LRBA, and involved in CTLA-4 trafficking as well as in vesicular trafficking in general. This work brings new knowledge to the regulation of CTLA-4 in activated T lymphocytes, a list of new partners for NBEAL2 protein and a new model of vesicular trafficking in which NBEAL2 is involved. Finally, a better understanding of the mechanisms leading to autoimmunity in patients with gray platelets syndrome could lead to better diagnosis and treatment management
Capítulos de livros sobre o assunto "Gray platelet syndrome"
Timson, David J., Richard J. Reece, James B. Thoden, Hazel M. Holden, Andrea L. Utz, Beverly M. K. Biller, Eugen-Matthias Strehle et al. "Gray Platelet Syndrome". In Encyclopedia of Molecular Mechanisms of Disease, 758–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_735.
Texto completo da fonteShahraki, Hojat, Akbar Dorgalaleh e Barbara J. Bain. "Gray Platelet Syndrome (GPS)". In Congenital Bleeding Disorders, 379–96. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-76723-9_16.
Texto completo da fonteKianinodeh, Fatemeh, Maryam Sadat Hosseini e Barbara J. Bain. "Gray Platelet Syndrome: Diagnosis and Management". In Congenital Bleeding Disorders, 445–63. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-43156-2_17.
Texto completo da fonteVagts, Dierk A., Heike Kaltofen, Uta Emmig e Peter Biro. "Grey-Platelet-Syndrom (UK)/Gray-Platelet-Syndrom (USA)". In Anästhesie bei seltenen Erkrankungen, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-44368-2_108-1.
Texto completo da fonteKöhler, M. "Grey-platelet-Syndrom: Pathophysiologie, Klinik, Diagnostik und Therapie". In Hämostaseologie, 67–71. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-662-07673-6_9.
Texto completo da fonte"Gray Platelet Syndrome". In Diagnostic Pathology: Blood and Bone Marrow, 322–25. Elsevier, 2018. http://dx.doi.org/10.1016/b978-0-323-39254-9.50068-4.
Texto completo da fontePozdnyakova, Olga. "Gray Platelet Syndrome". In Hematopathology, 37–38. Elsevier, 2013. http://dx.doi.org/10.1016/b978-1-4377-1758-7.00016-6.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Gray platelet syndrome"
Levy-Toledano, S., J. Enouf, M. Lebret, R. Bredoux e J. P. Caen. "ABNORMAL CALCIUM TRANSPORT INTO MICROSOMES OF GRAY PLATELET SYNDROME". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644747.
Texto completo da fonteMori, K., S. Suzuki, K. Sugai, Y. Akutsu, M. Ishikawa, H. Sakai e K. Hiwatashi. "INTRACELLULAR CA++ MOBILIZATION IN GRAY PLATELET SYNDROME. ELECTRONMICROSCOPIC STUDIES ON AEQUORIN LOADED PLATELETS". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644558.
Texto completo da fonteFACON, T., J. GOUPEMAND, C. CARON, M. ZANDECKI, M. H. ESTIENNE e A. COSSON. "GRAY PLATELET SYNDROME AND IDIOPATHIC PULMONARY FIBROSIS OCCURRING IN THE SAME PATIENT : A FORTUITOUS ASSOCIATION?" In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644559.
Texto completo da fonteLegrand, C., V. Dubernard, N. Kieffer e A. T. Nurden. "USE OF A MONOCLONAL ANTIBODY TO MEASURE THE SURFACE EXPRESSION OF THROMBOSPONDIN FOLLOWING PLATELET ACTIVATION". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643821.
Texto completo da fontePatscheke, H., e G. Mathieu. "MONITORING OF THE PLATELET ALPHA-GRANULE SECRETION IN THE AGGREGOMETER." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643492.
Texto completo da fonteForestier, F., F. Daffos, C. Kaplan e P. Champeix. "PRENATAL DIAGNOSIS OF HEMORRHAGIC DISORDERS". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644270.
Texto completo da fonteWautier, J. L., Y. Gruel, B. Boizard, J. P. Caen, F. Daffos e F. Forestier. "ANTENATAL DIAGNOSIS OF THROMBOPATHY". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644271.
Texto completo da fonteCockbill, S. R., S. Heptinstall e H. B. Burmester. "A PLASMA FACTOR FROM A PATIENT WITH A BLEEDING TENDENCY CAUSES PLATELET SECRETION IN THE ABSENCE OF EXTRACELLULAR CALCIUM". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643489.
Texto completo da fonteRendu, F., T. Hovig, P. Marche, M. Lebret, D. Tenza, J. Maclouf, J. P. Caen e S. Levy-Toledano. "MEMBRANE SIGNAL TRANSDUCTION IN PLATELETS WITH ALTERED RELEASE REACTION". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644746.
Texto completo da fonte